Seeking AlphaThu, 14 May 2026 01:00:42 GMTAlvotech (ALVO) Presents at Bank of America Global Healthcare Conference 2026 TranscriptALVO+3.38%
MarketBeatThu, 14 May 2026 00:14:22 GMTAlvotech Plans June FDA Resubmissions, Sees Biosimilar Approvals by Year-EndALVO+3.38%
Zacks Investment ResearchThu, 07 May 2026 02:45:53 GMTAlvotech (ALVO) Reports Q1 Loss, Lags Revenue EstimatesALVO+3.38%
Seeking AlphaFri, 10 Apr 2026 09:49:49 GMTAlvotech: Improving Fundamentals Signal A Potential Bottom For This Biosimilar PlayerALVO+3.38%
